Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades.

2017
  • Laura J van 't Veer
  • Tommy Fornander
  • Katherine A Hoadley
  • Alexander D Borowsky
  • Laura J Esserman
  • Nicholas P Tobin
  • Carlie K Thompson
  • Bo Nordenskj\xc3\xb6ld
  • Christopher C Benz
  • Linda S Lindstr\xc3\xb6m
  • Christina Yau
  • Olle St\xc3\xa5l
JAMA oncology